Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open label extension
New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label extension
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
04:25pm, Monday, 07'th Apr 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the BofA Securities 2025 Healthcare Conference on Tuesday, May 13th, 2025. Management will participate in a Fireside
Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes
09:40am, Monday, 07'th Apr 2025
Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.
Approval cements daratumumab as a foundational therapy in newly diagnosed multiple myeloma and the only anti-CD38 antibody for all patient types in this setting
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (April 2025)
08:00am, Saturday, 05'th Apr 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. The market is volatil
4 of Wall Street's Most Beloved Blue-Chip Dividend Stocks Are Sale-Priced April Bargains
07:15am, Saturday, 05'th Apr 2025
Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason.
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners
04:44pm, Friday, 04'th Apr 2025
With some pharmaceutical stocks paying 4% and higher dividends, they may be the perfect total return idea for the rest of 2025.
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
01:01pm, Friday, 04'th Apr 2025
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
TREMFYA® demonstrated clinically meaningful and statistically significant efficacy in patients with active psoriatic arthritis at risk for structural damage in Phase 3b study Topline results demonstr
JNJ vs. PFE: Which Drug Giant is a Better Buy Now?
11:00am, Thursday, 03'rd Apr 2025
Both JNJ & PFE expect their sales and profits to improve in 2025.
Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider
06:50pm, Wednesday, 02'nd Apr 2025
The latest trading day saw Johnson & Johnson (JNJ) settling at $155.36, representing a +1.38% change from its previous close.
Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.
06:15pm, Wednesday, 02'nd Apr 2025
The Nasdaq Composite (^IXIC 0.87%) and the S&P 500 (^GSPC 0.67%) sank, shifting in and out of correction territory in the first quarter of the year for one big reason: investors have been worried abou
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
04:15pm, Wednesday, 02'nd Apr 2025
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lu
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
12:26pm, Wednesday, 02'nd Apr 2025
Shares of Johnson & Johnson JNJ are trading higher on Wednesday. Yesterday, they were down more than 7.5%.
